{"id":"NCT00671853","sponsor":"University Hospitals Cleveland Medical Center","briefTitle":"Quetiapine Extended Release (XR) in Bipolar Patients With Comorbid Generalized Anxiety Disorder (GAD)","officialTitle":"Quetiapine XR in the Treatment of Comorbid Generalized Anxiety Disorder in Bipolar Depression With or Without Substance Use Disorder","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-04","primaryCompletion":"2011-03","completion":"2011-03","firstPosted":"2008-05-05","resultsPosted":"2013-10-11","lastUpdate":"2016-12-29"},"enrollment":120,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Bipolar Disorder","Anxiety","Anxiety Disorders","Substance Use Disorders"],"interventions":[{"type":"DRUG","name":"Quetiapine XR","otherNames":["Seroquel XR"]},{"type":"DRUG","name":"Placebo for quetiapine XR","otherNames":["Placebo for Seroquel XR"]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"PLACEBO_COMPARATOR"}],"summary":"The primary objective is to test the hypothesis that Quetiapine XR (Extended Release) monotherapy and adjunctive therapy is effective in the acute treatment of bipolar depression and comorbid generalized anxiety disorder in patients with bipolar disorder with or without a substance use disorder. The secondary aim is to generate an estimate of effect size to power a definitive large-scale, multi-site collaborative R01 and to configure the use of the primary and secondary outcome measures in the definitive large-scale study.","primaryOutcome":{"measure":"Change in the 17 Item Hamilton Rating Scale for Depression (HAM-D-17) Score","timeFrame":"Week 0 - Week 8","effectByArm":[{"arm":"Quetiapine XR","deltaMin":-9.91,"sd":16.45},{"arm":"Placebo for Quetiapine XR","deltaMin":-7.41,"sd":8.13}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":19},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["25007003"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":46},"commonTop":["Dry Mouth","Sedation","Dizziness","Headache","Stomach Upset"]}}